# Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury

> **NCT04493840** · PHASE4 · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 326 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Shenfu Injection
- **DRUG:** 5% Glucose Injection

## Key facts

- **NCT ID:** NCT04493840
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-30
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 326 (ESTIMATED)
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493840, "Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04493840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*